Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck-Reply
Overview
Overview
Journal
JAMA Oncol
Publisher
American Medical Association
Specialty
Oncology
Date
2023 Nov 22
PMID
37991775
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.